pain Archives -

FDA starts review of Pfizer, Lilly’s non-opioid painkiller

https://pharmaphorum.com/news/fda-starts-review-of-pfizer-lillys-non-opioid-painkiller/

Exclusive Speaker Interview with Stephen Hunt, Professor, UCL, ahead of Pain Therapeutics

https://pharmaphorum.com/partner-content/exclusive-speaker-interview-with-stephen-hunt-professor-ucl-ahead-of-pain-therapeutics/

Durect’s post-op painkiller splits FDA advisory panel

https://pharmaphorum.com/news/durects-post-op-painkiller-splits-fda-advisory-panel/

Nektar pulls pain drug after bruising FDA panel meeting

https://pharmaphorum.com/news/nektar-pulls-pain-drug-after-bruising-fda-panel-meeting/

Kaia to develop back pain app for US market after trial success

https://pharmaphorum.com/news/kaia-to-develop-back-pain-app-for-us-market-after-trial-success/

FDA rejects Heron’s non-opioid painkiller

https://pharmaphorum.com/news/fda-rejects-herons-non-opioid-painkiller/

Drug firm prosecuted for distributing opioids illegally

https://pharmaphorum.com/news/drug-firm-prosecuted-for-distributing-opioids-illegally/

R&D round-up: Non-opioid painkiller space heats up

https://pharmaphorum.com/views-and-analysis/rd-roundup-non-opioid-painkiller-space-heats-up/

Merck & Co pens $340m pain drug deal with KCL and Wellcome

https://pharmaphorum.com/news/merck-co-pens-340m-pain-drug-deal-with-kcl-and-wellcome/

Search